CSF neurofilament light: A universal risk biomarker in multiple sclerosis?

Affiliations

¹ From the Department of Neurology (M.K.), Medical University of Graz, Austria; and Department of Neurology (J.S.), Umeå University Hospital, Sweden. michael.khalil@medunigraz.at.
² From the Department of Neurology (M.K.), Medical University of Graz, Austria; and Department of Neurology (J.S.), Umeå University Hospital, Sweden.

Editorial

Michael Khalil et al. Neurology. 2016.

. 2016 Sep 13;87(11):1068-9.

doi: 10.1212/WNL.0000000000003107. Epub 2016 Aug 12.

¹ From the Department of Neurology (M.K.), Medical University of Graz, Austria; and Department of Neurology (J.S.), Umeå University Hospital, Sweden. michael.khalil@medunigraz.at.
² From the Department of Neurology (M.K.), Medical University of Graz, Austria; and Department of Neurology (J.S.), Umeå University Hospital, Sweden.

No abstract available

Comment on

Neurofilament light chain level is a weak risk factor for the development of MS.
Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cermeño JC, Picón C, Kuhle J, Disanto G, Kappos L, Sastre-Garriga J, Pareto D, Simon E, Comabella M, Río J, Nos C, Tur C, Castilló J, Vidal-Jordana A, Galán I, Arévalo MJ, Auger C, Rovira A, Montalban X, Tintore M. Arrambide G, et al. Neurology. 2016 Sep 13;87(11):1076-84. doi: 10.1212/WNL.0000000000003085. Epub 2016 Aug 12. Neurology. 2016. PMID: 27521440 Free PMC article.